Locations:

Multiple Sclerosis

stylized illustration of a CAR T receptor

Encouraging 90-Day Results for Allogeneic CAR T-Cell Therapy for Progressive Multiple Sclerosis

Phase 1 trial of azer-cel reports good preliminary safety and efficacy

mosquito on human skin

Rare New Neuroinvasive Threat Identified for Patients on B Cell-Depleting Therapy

Milestone case report expands understanding of infectious risks for those on immunomodulatory therapies

floating CAR T cell against background of other cells

Zola-Cel CAR T-Cell Therapy Shows Promising Initial Results in Multiple Sclerosis

Phase 1 Breakfree-2 trial reports good safety and efficacy at week 26

scan of a human brain

Study Links ANNA1/Hu-IgG Paraneoplastic Neurological Syndromes With Longer Cancer Survival

Findings may have implications for understanding the disorders’ pathophysiology

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

woman looking concerned as she listens to a doctor speak to her

Study Offers First Characterization of Patients With Nonspecific Presentations of Multiple Sclerosis

Nearly one-fifth of such cases fulfill 2024 McDonald criteria based on biomarkers

portrait of Dr. Jeffrey Cohen against decorative background with podcast icon overlay
June 16, 2026/Neurosciences/Podcast

The Potential of CAR T-Cell Therapy in Multiple Sclerosis (Podcast)

Updates on this fast-evolving therapeutic landscape from a leading trialist

middle-aged woman looking down sadly while sitting on a bed

Multiple Sclerosis Progression in Midlife Women: Disentangling Reproductive and Somatic Aging

Two research projects aim to enable more personalized MS care in this population

neuron-affected-by-neuromyelitis-optica

NMOSD: Multiple Monoclonal Antibodies Have Expanded Treatment Options

How to use? Consider starting during the acute attack and seek patient preferences for chronic use

stylized illustration of a chemical compound made up of connected multicolor spheres

What’s the Outlook for BTK Inhibitors in Progressive Multiple Sclerosis?

Despite safety concerns and mixed trial results, experts see potential for this indication

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

BackPage 1 of 7Next

Advertisement

Ad